(19)
(11) EP 1 753 413 A2

(12)

(43) Date of publication:
21.02.2007 Bulletin 2007/08

(21) Application number: 04817279.5

(22) Date of filing: 22.10.2004
(51) International Patent Classification (IPC): 
A61K 31/00(2006.01)
(86) International application number:
PCT/EP2004/052639
(87) International publication number:
WO 2005/039550 (06.05.2005 Gazette 2005/18)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR
Designated Extension States:
AL HR LT LV MK

(30) Priority: 24.10.2003 EP 03103961
27.10.2003 EP 03103967

(71) Applicant: Solvay Pharmaceuticals GmbH
30173 Hannover (DE)

(72) Inventors:
  • ANTEL, Jochen
    31848 Bad Münder (DE)
  • GREGORY, Peter-Colin
    30559 Hannover (DE)
  • WALDECK, Harald
    30916 Isernhagen HB (DE)
  • KRAUSE, Günter
    31303 Burgdorf (DE)
  • LANGE, Josephus, Hubertus, Maria
    NL-1325 LP Almere (NL)
  • KRUSE, Chris
    NL-3816 BJ Amersfoort (NL)

(74) Representative: Gosmann, Martin 
Solvay Pharmaceuticals GmbH Hans-Böckler-Allee 20
30173 Hannover
30173 Hannover (DE)

   


(54) NOVEL MEDICAL USES OF COMPOUNDS SHOWING CB SB 1/SB -ANTAGONISTIC ACTIVITY AND COMBINATION TREATMENT INVOLVING SAID COMPOUNDS